GUEST Speakers
FCDFI 2nd Quarterly Webinar
Embedded Files
Dr. Myra Elliott
Dr. Myra Elliott
Lecture Title
"What Every Dentist Should Understand About Medication Related Osteonecrosis of the Jaw"
Abstract
This is a condition that has been reported since 2003 – when patients developed necrotic portions of their jaw bones which were potentially debilitating. Since then, it is recognized that the same patients were put on either anti-resorptive or antiangiogenic drugs for various medical conditions. What and why were these drugs prescribed is discussed in this presentation.
The incidence and risk factors of developing MRONJ are discussed. A detailed description of the clinical stages MRONJ to help dentist to recognise the condition.
Then, as dentists how do we deal this condition:- from observation to local debridement or sequestrectomy to resection of the necrotic bone with reconstruction.
Many preventive dental procedures are discussed with to avert this rather debilitating condition.
Course objective
The understanding of the condition called Medication related osteonecrosis of the Jaws, what is the cause of which. And how as dentist we can deal, treat and prevent this quite debilitating condition
Bionote
Dr. Myra Elliott attained her basic BDS in 1968 from the University of Singapore. She spent many years in the United Kingdom and had her postgraduate training in the University of Sheffield, where she specialized in Oral and Maxillofacial surgery. After 15 years in the UK, she did the reverse immigration and returned to Singapore.
Dr. Elliott believes in “Dentistry Beyond Borders.” This philosophy was the inspiration behind her extensive volunteer work and her founding of Global Clinic, a charity organisation that started in 1997 involving a group of doctors who were looking to make a difference in a region rife with poverty. These charitable efforts have since snowballed into a tremendous force of goodness that has changed the lives of 30,000 people. Since 1986, she has been passionately involved in doing voluntary work, providing medical and dental care to the poor and remote communities of Southeast Asian countries and further afield to Pakistan, India, the Himalayas and Africa.
She also volunteers at the Singapore Zoological Gardens – assisting and providing care of animals' teeth.
Dr. Elliott is an honorary consultant in several hospitals since 1987. She conducts lectures internationally as well as in National University of Singapore on all aspects of her specialties.
Dr. Elliott has a special interest in reconstructive surgery for infants/children with cleft lip/palate. She also has expertise in dealing with maxillofacial trauma, benign and malignant tumors of the face, chronic facial pain disorders, temporomandibular joint disorders and corrective orthognathic surgery, on top of all aspects of dentoalveolar disorders.
Irene Rosellen P. Tan, RMT, MD, FPCP
Irene Rosellen P. Tan, RMT, MD, FPCP
Lecture Title
"COVID-19 and Dentistry: Do’s and Don'ts"
Bionote
Doctor of Medicine (Cum Laude), University of Santo Tomas - Faculty of Medicine and Surgery
Internal Medicine Residency, National Kidney and Transplant Institute
Pulmonary Medicine Fellowship, UP - Philippine General Hospital
Fellow, Philippine College of Physicians
Associate Member, Philippine College of Chest Physicians
Member, Asian Pacific Society of Respirology
Medical/COVID ICU Intensivist - St. Luke’s Medical Center - Global City
Consultant (DOH program), Division of Pulmonary Medicine, UP- Philippine General Hospital
ICC 2017 Young Investigator Travel Award - 30th International Congress of Chemotherapy and Infection, 2017 November 24-27; Taipei, Taiwan for the research study entitled “Impact of Early Antibiotic Therapy (EAT) on Outcome of Patients with Sepsis at the Emergency Room of National Kidney and Transplant Institute”
Current sub-investigator of COVID-19 vaccine trials:
ENSEMBLE 2: A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older
Thank you for attending!
Thank you for attending!
Page updated
Google Sites
Report abuse